BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang RC, Neo JC, Lo SL, Tan GS, Seow TK, Chung MC. Proteome database of hepatocellular carcinoma. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;771:303-328. [PMID: 12016006 DOI: 10.1016/s1570-0232(02)00041-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Herencia C, Martínez-Moreno JM, Herrera C, Corrales F, Santiago-Mora R, Espejo I, Barco M, Almadén Y, de la Mata M, Rodríguez-Ariza A. Nuclear translocation of β-catenin during mesenchymal stem cells differentiation into hepatocytes is associated with a tumoral phenotype. PLoS One. 2012;7:e34656. [PMID: 22506042 DOI: 10.1371/journal.pone.0034656] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
2 Borlak J, Singh P, Gazzana G. Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events. BMC Genomics 2015;16:124. [PMID: 25872475 DOI: 10.1186/s12864-015-1312-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Bertram K, Valcu CM, Weitnauer M, Linne U, Görlach A. NOX1 supports the metabolic remodeling of HepG2 cells. PLoS One 2015;10:e0122002. [PMID: 25806803 DOI: 10.1371/journal.pone.0122002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
4 Khare T, Khare S, Ibdah JA. Proteomics approaches for early detection and targeted therapy of hepatocellular carcinoma. World J Gastrointest Oncol 2017; 9(1): 1-3 [PMID: 28144394 DOI: 10.4251/wjgo.v9.i1.1] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 撒忠秋, 秦建民, 倪雷. 蛋白质组学在肝癌发生机制及诊治中的作用. 世界华人消化杂志 2010; 18(15): 1521-1524 [DOI: 10.11569/wcjd.v18.i15.1521] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Zhou T, Li Y, Yang L, Tang T, Zhang L, Shi J. Annexin A3 as a Prognostic Biomarker for Breast Cancer: A Retrospective Study. Biomed Res Int 2017;2017:2603685. [PMID: 28497041 DOI: 10.1155/2017/2603685] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
7 Gu DL, Chen YH, Shih JH, Lin CH, Jou YS, Chen CF. Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma. World J Gastroenterol 2013; 19(47): 8873-8879 [PMID: 24379610 DOI: 10.3748/wjg.v19.i47.8873] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
8 Megger DA, Bracht T, Kohl M, Ahrens M, Naboulsi W, Weber F, Hoffmann AC, Stephan C, Kuhlmann K, Eisenacher M, Schlaak JF, Baba HA, Meyer HE, Sitek B. Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study. Mol Cell Proteomics 2013;12:2006-20. [PMID: 23462207 DOI: 10.1074/mcp.M113.028027] [Cited by in Crossref: 81] [Cited by in F6Publishing: 40] [Article Influence: 10.1] [Reference Citation Analysis]
9 Zabielska-Koczywąs K, Michalak K, Wojtalewicz A, Winiarczyk M, Adaszek Ł, Winiarczyk S, Lechowski R. Proteomic Differences in Feline Fibrosarcomas Grown Using Doxorubicin-Sensitive and -Resistant Cell Lines in the Chick Embryo Model. Int J Mol Sci 2018;19:E576. [PMID: 29443940 DOI: 10.3390/ijms19020576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]